Embolization Coils Market Analysis

Type (Detachable Coil, Pushable Coil)

The detachable coil segment in the embolization coils market is estimated to gain a robust revenue share of 60% in the coming years owing to the growing usage in various clinical applications. Detachable coils function by promoting flow stasis and triggering thrombosis and were created to completely embolise aneurysms. They are injected through a catheter that is implanted into a groin artery into the aneurysm lumen to provide a secure and reliable substitute for surgically cutting cerebral aneurysms. Besides this, the coil has proven to be safer and easier to deploy and also offers additional advantages such as dependability in attaining vascular blockage.

Application (Urology, Oncology, Peripheral Vascular Disease, Neurology, Cardiology)

Embolization coils market from the neurology segment is set to garner a notable share shortly on the account of growing cases of arteriovenous malformations (AVMs). For cerebral arteriovenous malformations (AVMs), endovascular embolization is regarded as a curable treatment as it aims to remove the AVM nidus, and aid in obstructing blood flow and preventing hemorrhage, by using imaging guidance to insert a tiny, soft metal coil or quick-drying glue inside the AVM. Furthermore, embolization is developing as a safe and effective method for treating deep or inoperable AVMs since they are less invasive than surgery and can be used to lessen the size and symptoms of an AVM.

Our in-depth analysis of the global embolization coils market includes the following segments:

Application	Neurology Cardiology Urology Oncology Peripheral Vascular Disease
Material	Platinum Platinum & Hydrogel Platinum Tungsten Alloy
Type	Detachable Coil Pushable Coil
End-User	Cardiac Center Hospitals Ambulatory Center

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of embolization coils is assessed at USD 2.48 billion.

The embolization coils market size was valued at USD 2.25 billion in 2024 and is expected to reach USD 4.98 billion by 2037, registering around 6.3% CAGR during the forecast period i.e., between 2025-2037. Growing cases of cancer across the globe and the growing usage in hematuria management will boost the market growth.

North America industry is predicted to dominate majority revenue share of 41% by 2037, impelled by growing spending in healthcare.

The major players in the market are Boston Scientific Corporation, DePuy Synthes, Medtronic, St. Jude Medical, Sirtex, Cook Medical, Cordis Corporation, Johnson & Johnson Services, Inc., Shape Memory Medical, Inc.

Embolization Coils Market Analysis